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Gram-negative Burkholderia cepacia complex (Bcc)
isolates were screened for antimicrobial activity
against cystic fibrosis microbial pathogens, and the
ability of B. ambifaria to inhibit B. multivorans was
identified. The activity was mapped to a cluster of
cryptic, quorum-sensing-regulated modular polyke-
tide synthase (PKS) genes. Enacyloxin IIa and its
stereoisomerdesignated iso-enacyloxin IIawere iden-
tified asmetabolic products of the gene cluster, which
encodedanunusualhybridmodularPKSconsistingof
multiple proteins with sequence similarity to cis-acyl-
transferase (cis-AT) PKSs and a single protein with
sequence similarity to trans-AT PKSs. The discovery
of the potent activity of enacyloxins against drug-
resistant bacteria and the gene cluster that directs
their production provides an opportunity for engi-
neered biosynthesis of innovative enacyloxin deriva-
tives and highlights the potential of Bcc bacteria as
an underexploited resource for antibiotic discovery.
INTRODUCTION
Bacteria within the Gram-negative genus Burkholderia are well
known for their phenotypic and genotypic diversity (Coenye
and Vandamme, 2003). The Burkholderia cepacia complex
(Bcc) is a subgroup of closely related Burkholderia species that
reflect this functional multiplicity by demonstrating biopesticidal
interactions at the plant rhizosphere (Parke and Gurian-
Sherman, 2001), a capacity for the bioremediation of aromatic
hydrocarbon pollutants (Chain et al., 2006; O’Sullivan et al.,
2007), and also the ability to cause devastating lung infections
in individuals with cystic fibrosis (CF) (Mahenthiralingam et al.,
2005). The taxonomy of B. cepacia complex isolates has under-
gone extensive revision over the last decade, with expansion
from 1 to 17 formally named Bcc species (Mahenthiralingam
et al., 2008; Vanlaere et al., 2009). All Bcc bacteria possess
intrinsic resistance to a range of antimicrobial compoundsChemistry & Biology 18,including antibiotics and biocides (Rose et al., 2009), and infec-
tions in patients with CF are difficult to treat with currently
available antibiotics (Chernish and Aaron, 2003). Outside of CF
infection, the rhizosphere is the best-characterized environ-
mental habitat of Bcc bacteria (Parke and Gurian-Sherman,
2001), where their biopesticidal ability to protect crops from
fungal and nematodal pathogens has been linked in part to their
ability to biosynthesize a range of antibiotic or toxic secondary
metabolites (Parke and Gurian-Sherman, 2001; Vial et al., 2007).
Antifungal antibiotics known to be produced by Bcc species
include cepacin, cepaciamide, xylocandins, quinolinones, phe-
nylpyrroles, and phenazines (Parke and Gurian-Sherman, 2001;
Vial et al., 2007). An antifungal nonribosomally biosynthesized lip-
opeptide, AFC-BC11, has been genetically characterized in
B. cepacia strain BC11 (Kang et al., 1998), and the recently
described Burkholdines 1097 and 1229 are antifungal cyclic
lipopeptides produced by B. ambifaria 2.2N (Tawfik et al.,
2010). One of the most well known Bcc antibiotics is
pyrrolnitrin, a broad-range antifungal phenylpyrrole that has
been recently found to be produced by several Bcc species
under the control of quorum sensing (QS) (Schmidt et al., 2009).
Burkholderia secondary metabolites may also have multiple
functions, such as the 4-quinolinones which were originally
characterized as antifungal antibiotics and plant growth-
promoting agents (Moon et al., 1996), and more recently deriva-
tives such as 2-heptyl-3-hydroxy-4(1H)-quinolone have also
been shown to act as a quorum-sensing signal in B. ambifaria
and other non-Bcc Burkholderia species (Diggle et al., 2006;
Vial et al., 2008). Several studies have demonstrated that
non-Bcc Burkholderia species are capable of producing polyke-
tide antibiotics such as the rhizoxin toxin which causes rice blight
(Partida-Martinez and Hertweck, 2007), the bactobolins which
have antibacterial activity (Seyedsayamdost et al., 2010), and
the food-related toxin bronkrecic acid (Rohm et al., 2010). In
addition to the identification of antimicrobials naturally produced
by Burkholderia bacteria, Knappe et al. (2008) used a genome-
mining approach to isolate capistruin, a lasso peptide encoded
by the B. thailandensis genome. Bioinformatic analysis of the ke-
tosynthase (KS) domains of trans-acyltransferase (AT) polyketide
synthase (PKS)-encoding genes also enabled the identification of
thailandamide polyketides within the B. thailandensis genome
and their subsequent biological analysis (Nguyen et al., 2008).665–677, May 27, 2011 ª2011 Elsevier Ltd All rights reserved 665
Figure 1. The Novel Anti-Gram-Negative Activity of B. ambifaria
The results of a B. ambifaria strain AMMD antimicrobial screening assay are
shown for overlays with three multidrug-resistant bacteria in (A): Bm,
B. multivorans C1576 (Glasgow outbreak strain); Bd, B. dolosa LMG 18943
(Boston outbreak strain); and Ab, A. baumannii OXA23 clone 2. The antimi-
crobial phenotypes of wild-type B. ambifaria strain AMMD, a rapid secretor
mutant (11-8-2), and two PKS mutants within the biosynthesis island (21-7-2
and 9-11-5) are shown against overlays of B. multivorans (Bm), S. aureus (Sa),
and C. albicans (Ca) in (B). The gene inactivated by the transposon insertion is
shown in brackets (see Table 2). The figure comprises a composite of pro-
portionately cropped images of overlay assays, and a scale bar of 10 mm is
shown in each panel to indicate the size of the zone of antimicrobial inhibition.
See also Figures S1 and S2.
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Enacyloxin Biosynthesis in B. ambifariaGiven the extent to which the taxonomic description of Bcc
species has changed and the limited number of antibiotics char-
acterized in well-defined Burkholderia species (Schmidt et al.,
2009; Seyedsayamdost et al., 2010; Tawfik et al., 2010; Vial
et al., 2007), we performed a systematic survey of antimicrobial
activity across a large collection of genetically typed Bcc strains.
In addition, because it has been anecdotally observed that CF
sputum appears less polymicrobial once chronic infection with
aBcc isolate is established,we also specifically screened for Bcc
antagonism toward other CF pathogens such as Pseudomonas
aeruginosa, Staphylococcus aureus, the yeast Candida albicans,
as well as other Bcc species (Lipuma, 2010). A broad range of
antimicrobial Bcc phenotypes was observed, the most remark-
able of which was the activity against multidrug-resistant
(MDR) Gram-negative bacteria shown by B. ambifaria, a species
previously known for its antifungal and biopesticidal properties
(Coenye et al., 2001). Using transposon mutagenesis, we map-
ped the genes responsible for the antibacterial activity to a puta-
tive polyketide biosynthesis island within the genome of
B. ambifaria AMMD, and together with global gene expression
identified multiple accessory loci required for antibiotic biosyn-
thesis. Purification and spectroscopic analysis of the com-
pounds responsible for the anti-Gram-negative activity identified
them as enacyloxins (Watanabe et al., 1982), unusual polyene
antibiotics that target protein biosynthesis by inhibition of the
ribosomal elongation factor Tu (Parmeggiani et al., 2006).
LC-MS analyses confirmed that enacyloxin production was
abolished in the transposon mutants. Sequence comparisons
of the enzymes encoded by genes within the enacyloxin biosyn-
thetic gene cluster suggest a complete hypothetical pathway for
enacyloxin biosynthesis involving an extremely unusual hybrid
PKS composed of proteins with sequence similarity to both the
phylogenetically distinct cis-AT and trans-AT PKS families
(Piel, 2010), several PKS modules with sequence similarity to
cis-AT proteins that lack AT domains, a unique mechanism for
polyketide chain release, and both nonheme iron- and flavin
adenine dinucleotide (FAD)-dependent chlorinases. The enacy-
loxins appear to be one of an armory of antimicrobial compounds
synthesized by B. ambifaria, and the mapping of their biosyn-
thetic pathway reflects the remarkable diversity of antimicrobial
functions that can be acquired and expressed by these versatile
bacteria.
RESULTS
Prevalence of Antimicrobial Activity within the Bcc
An initial screen for antimicrobial activity was performed on nine
genome-sequenced Bcc strains and nine other representative
isolates (see Experimental Procedures). To stimulate secondary
metabolite production, Bcc bacteria were (1) grown on aminimal
medium containing glycerol, a carbon source that often
promotes antibiotic production (Keum et al., 2009); (2) incubated
for 5 days such that stationary phase was reached; and (3)
grown as a dense single colony where biofilm- and quorum-
sensing interactions could promote alternative metabolism and
catabolism (see Experimental Procedures). After growth, the
Bcc strains were overlaid with B. multivorans and a zone of
clearing was observed around the B. ambifaria AMMD colony
(Figure 1A). The demonstration of novel anti-Gram-negative666 Chemistry & Biology 18, 665–677, May 27, 2011 ª2011 Elsevieractivity in B. ambifaria was expanded to a systematic screen
of 268 Bcc isolates, comprising 13 named species and 5
novel subgroups within the complex (Table 1); 228 of these
isolates were genetically distinct strains by multilocus sequence
typing (MLST) (Baldwin et al., 2005), and the collection
possessed a similar number of isolates from clinical infections
(43%) and from the natural environment (57%). Antimicrobial
activity against a panel of CF pathogens including Gram-nega-
tive bacteria (P. aeruginosa and B. multivorans), Gram-positive
bacteria (S. aureus), and fungi (C. albicans) was examined
(Table 1).
No antagonism toward P. aeruginosa was observed; how-
ever, 32% of the Bcc isolates demonstrated anticandidal
properties and 24% were capable of inhibiting the growth of
S. aureus (Table 1). B. cepacia, B. cenocepacia, B. stabiliz,
B. vietnamiensis, and B. ambifaria were active against S. aureus,Ltd All rights reserved
Table 1. Collection of B. cepacia Complex Isolates Screened for Antimicrobial Activity
Species or Bcc Subgroup
Number of Isolates
(Clinical/Environmental)
Number of Strains (Based on
MLST Sequence Types)
Number with Antimicrobial Activitya
(% Isolates within Each Bcc Species)
B. multivorans S. aureus C. albicans
B. cepacia 30 (15/15) 29 0 11 (37) 14 (47)
B. multivorans 24 (20/4) 24 0 0 0
B. cenocepacia III-A 28 (25/3) 22 0 8 (29) 1 (4)
B. cenocepacia III-B 30 (11/19) 27 0 9 (30) 7 (23)
B. stabilis 16 (10/6) 7 0 9 (56) 0
B. vietnamiensis 16 (5/11) 12 0 7 (44) 7 (44)
B. dolosa 8 (8/0) 5 0 0 0
B. ambifaria 46 (6/40) 43 6 (13) 17 (37) 21 (46)
B. anthina 14 (4/10) 9 0 1 (7) 6 (43)
B. pyrrocinia 16 (2/14) 13 0 1 (6) 9 (56)
B. arboris 3 (1/2) 3 0 0 0
B. diffusa 1 (0/1) 1 0 0 0
B. lata 10 (1/9) 8 0 1 (10) 4 (40)
B. contaminans 6 (4/2) 6 0 0 3 (50)
Bcc group K (novel) 1 (0/1) 1 0 0 0
BCC4 3 (1/2) 3 0 0 3 (100)
BCC5 5 (2/3) 5 0 0 3 (60)
BCC6 10 (0/10) 9 0 0 7 (70)
BCC8 1 (1/0) 1 0 0 0
Total 268 (116/152) 228 6 (2.2) 64 (24) 85 (32)
a A zone of clearingR10 mm was scored as positive for antimicrobial activity.
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Enacyloxin Biosynthesis in B. ambifariawith greater than 29% of isolates in each species producing
inhibition zones; the same Bcc species were also highly antago-
nistic toward C. albicans (Table 1). Antifungal activity was
also seen in B. anthina, B. pyrrocinia, B. arboris, B. lata,
B. contaminans, and several of the novel Bcc MLST groups
(Table 1). No antagonistic activity was observed for any
B. multivorans, B. stabilis, B. dolosa, B. arboris, or B. diffusa
isolates tested (Table 1). Anti-Gram-negative activity was not
common in the Bcc (Table 1); however, six B. ambifaria isolates
strongly inhibited the growth of B. multivorans (Figure 1), and the
genome-sequenced species-type strain for B. ambifaria, strain
AMMD (Coenye et al., 2001) (see http://www.burkholderia.com)
was selected for further study of this novel activity.
B. ambifaria Produces an Antimicrobial Active
on Other Bcc Bacteria
B. ambifaria AMMD inhibited the growth of all B. multivorans
(n = 11) and B. dolosa (n = 7) strains tested. Notably, the
AMMD antimicrobial was also active against pan-resistant
Gram-negative strains such as the B. multivorans Glasgow CF
strain (Rose et al., 2009), B. dolosa Boston CF strain (Kalish
et al., 2006), and Acinetobacter baumannii OXA23 clone 2
(Coelho et al., 2006) (Figure 1A). B. cepacia, B. cenocepacia,
B. stabilis, B. vietnamiensis, B. ambifaria, B. lata, and B. diffusa
were all resistant to the B. ambifaria AMMD antimicrobial; both
susceptible and resistant strains were found among the
B. vietnamiensis, B. pyrrocinia, and B. anthina strains examined.
The unique anti-Gram-negative activity of B. ambifaria was
designated ‘‘B. ambifaria antimicrobial on B. multivorans’’Chemistry & Biology 18,(BAMM). Secretion of BAMM was not constitutive and remained
cryptic unless it was induced by growth on carbon sources such
as glycerol and ribose and the cultures allowed to reach
stationary phase (approximately 30 hr at 30C).
The Genetic Basis of B. ambifaria Anti-Gram-Negative
Activity
Transposon mutagenesis (O’Sullivan et al., 2007) was used to
identify genes required for the biosynthesis of BAMM in
B. ambifaria AMMD. Of 1920 mutants screened, 22 with an
altered BAMM phenotype (Figure 1B) were identified and
mapped to the AMMD genome (Table 2). Four transposon inser-
tions mapped to chromosome 1 (Table 2): mutations within
general secretory pathway genes either stopped BAMMproduc-
tion or reduced it; mutation of a type I glycosyltransferase within
an exopolysaccharide gene cluster gave a BAMM-negative
phenotype; and transposon insertion into an AraC-type tran-
scriptional regulator coding sequence (CDS) resulted in early
onset of BAMM secretion (a zone of clearing was seen after
18 hr). The same rapid secretion phenotype was seen with muta-
tion of a cation diffusion facilitator family transporter gene
(Bamb_5056, mutant 11-8-2) encoded on chromosome 2
(Table 2), which also demonstrated greater anticandidal activity
than the wild-type (Figure 1B). Five independently isolated
BAMM-negative mutants mapped to the same locus on
chromosome 2, a hypothetical gene, Bamb_5367, adjacent to
a recombination hot spot (RHS) element, Bamb_5366, encoding
a valine-glycine-rich protein (VGR) protein. Another interesting
chromosome 2 mutation which stopped BAMM secretion was665–677, May 27, 2011 ª2011 Elsevier Ltd All rights reserved 667
Table 2. Transposon Mutants of B. ambifaria AMMD with Altered BAMM Properties
Mutant Name
(Chromosomal Location)
BAMM
Phenotype Gene Putative Function
Microarray Expression Analysisa
Fold Change p Value
Chromosome 1
4-11-5 Negative Bamb_0051 General secretory pathway protein E 2.354 0.00412
3-12-1 Weakb Bamb_0052 General secretory pathway protein D 2.415 0.00571
5-5-3 Negative Bamb_0758 Glycosyltransferase, group 1 6.581 0.00844
5-3-7 Rapidc Bamb_2222 Transcriptional regulator, AraC family - -
Chromosome 2
5-7-2 Negative Bamb_4118 Autoinducer synthase, CepI 2.183 0.0469
9-7-2 Negative Bamb_4118 Autoinducer synthase, CepI 2.183 0.0469
11-8-2 Rapidc Bamb_5056 Cation diffusion facilitator family transporter - -
10-11-3 Negative Bamb_5367 Hypothetical protein - -
8-7-6 Negative Bamb_5367 Hypothetical protein
11-10-3 Negative Bamb_5367 Hypothetical protein
13-12-6 Negative Bamb_5367 Hypothetical protein
1-9-5 Negative Bamb_5367 Hypothetical protein
Chromosome 3
20-11-1 Negative Bamb_5910 Transcriptional regulator, LuxR family 4.079 0.00071
9-11-5 Negative Bamb_5919 trans-AT modular PKS 92.17 0.00172
18-3-4 Negative Bamb_5921 cis-AT modular PKS 72.21 0.00049
16-6-5 Negative Bamb_5921 cis-AT modular PKS 72.21 0.00049
15-4-3 Negative Bamb_5924 cis-AT modular PKS 8.829 0.00209
9-3-8 Negative Intergenic
Bamb_5924–5925
cis-AT modular PKS - -
21-7-2 Negative Bamb_5925 cis-AT modular PKS 159.5 0.00119
19-11-4 Negative Bamb_5926 Type II thioesterase 1.89 0.00903
20-6-6 Negative Bamb_5928 FADH2-dependent chlorinase 292.7 0.00176
2-6-7 Negative Bamb_6239 UDP-glucuronosyl/UDP-glucosyltransferase - -
See also Table S4.
a Further information on the alterations in gene expression observed during antibiotic production are shown in Table S4 and Supplemental Information
file B_ambifaria_genes_induced_by_glycerol.xls.
bWeak zone of clearing <10 mm observed around the B. ambifaria AMMD mutant.
c Secretion of BAMM appeared after 18 hr of growth as indicated by a small but clear zone of clearing >10 mm.
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Enacyloxin Biosynthesis in B. ambifariathat of Bamb_4118 (two independent mutants; Table 2),
a homolog of the acyl homoserine lactone (AHL) synthase,
CepI, associated with Gram-negative QS systems (Malott
et al., 2005). The lack of BAMM secretion in the cepImutant sug-
gested that QS plays an integral role in activating antibiotic
biosynthesis correlating to the stationary phase growth onset
of BAMM secretion.
Nine mutants mapped to the same region on chromosome 3,
a large genomic island (87.4 kb; coordinates 392535–479734)
with a 71.5% GC content compared to the 66.5% GC average
for this B. ambifaria AMMD replicon. The island spanned 33
coding sequences (Bamb_5910–5943; see Table S1 available
online for function and homology data). Several CDSs encoded
proteins with similarity to known modular PKSs, suggesting the
BAMM antimicrobial was a polyketide (Nguyen et al., 2008;
Zerikly and Challis, 2009). The organization of the 24 genes
within the island is shown in Figure 2. Transposon mutations re-
sulting in a BAMM-negative phenotype were mapped to four of
the seven PKS CDSs (Figure 2 and Table 2). Transposon inser-
tions mapped to a type II thioesterase (proposed in other668 Chemistry & Biology 18, 665–677, May 27, 2011 ª2011 Elseviersystems to maintain PKS activity by catalyzing hydrolysis of
aberrant intermediates that block procession of the growing pol-
yketide chain along the PKS), and FADH2-dependent chlorinase
upstream of these genes also abrogated BAMM production
(Table 2 and Figure 2). Downstream of the PKS genes and at
the far end of the genomic island were two genes encoding
putative LuxR-type regulators, one of which, Bamb_5910, was
mapped by a transposon insertion which resulted in a BAMM-
negative phenotype. Because mutation of the Bamb_4118 AHL
synthase had also prevented BAMM secretion, it was not
surprising to find that mutation of a LuxR regulator within the
island stopped production of the antimicrobial.
Transposon inactivation of the PKS genes (Figure 2) resulted in
mutants that produce no zones of inhibition in the B. multivorans
overlay assays (data shown for the Bamb_5925 and Bamb_5919
mutants, 21-7-2 and 9-11-5, respectively, in Figure 1B). These
PKSmutants still produced a zone of inhibition against S. aureus,
although the activity was weaker than the wild-type (Figure 1B).
Interestingly, the anticandidal activity of B. ambifaria AMMDwas
unaffected bymutation of the PKS genes (Figure 1B), suggestingLtd All rights reserved
Figure 2. Genetic Organization of the B. ambifaria AMMD Polyketide Biosynthesis Island
The arrangement of 24 genes within the polyketide biosynthesis island is shown as three panels, each drawn to the scale given by the bars on the right of each
respective panel. The functional contribution of each gene to polyketide biosynthesis is shown by the color-coded key, and genes mapped by transposon
mutagenesis (see Table 2) are indicated. All genes in the pathway shown above were significantly upregulated under antibiotic-inducing growth conditions (see
Table S4) except Bamb_5913 (*). Homology data to support the putative function of each gene are provided in Table S1, with the microarray demonstrating
upregulation of the gene cluster during enacyloxin production-inducing growth conditions provided in Table S4.
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Enacyloxin Biosynthesis in B. ambifariathat the polyketide antibiotic being produced from the PKS
cluster had limited antifungal activity as detected by the colony
overlay assay. None of the transposon mutants demonstrated
increased susceptibility to the AMMD polyketide when they
were themselves overlaid onto a wild-type B. ambifaria AMMD
colony, indicating that the genes identified as essential for
BAMM production (Table 2) did not play a role in self-resistance
to the secreted antimicrobial. PCR primers designed to detect
three PKS-encoding genes, Bamb_5925, Bamb_5921, and
Bamb_5919 (Figure 2), amplified the corresponding loci from
five other B. ambifaria strains (BCC0118, BCC0203, BCC0250,
BCC0480, and BCC1254) that also demonstrated BAMMactivity
(Table 1). The positive bioactivity and presence of homologous
genes spanning the PKS region suggested that all these
B. ambifaria isolates possessed a functional BAMM polyketide
biosynthesis island even though each was a genetically distinct
strain by MLST.
Isolation and Structure Elucidation of the Metabolic
Product of the Cryptic BAMM Polyketide Biosynthetic
Gene Cluster
Adsorption of the presumed polyketide product of the conserved
genomic island onto XAD-16, a neutral crosslinked polystyrene
resin that adsorbs erythromycin from solution (Ribeiro and
Ribeiro, 2003), was investigated as an initial step in the isolation
of the BAMM activity. Active methanol eluates were obtained
from adsorption of the supernatants of liquid cultures and
aqueous washes of the agar from solid-medium growth ofChemistry & Biology 18,B. ambifaria AMMD (see Experimental Procedures). The eluates
obtained from agar-grown bacteria proved most stable, and
LC-MS analysis indicated that they contained several
compounds. The eluates were therefore further fractionated
by semipreparative HPLC, and each fraction was analyzed by
high-resolution electrospray ionization mass spectrometry
(HR-ESI-MS).
One fraction afforded ions with m/z = 256.1694 and 258.1848
(Figure S1). The molecular formulas deduced for these ions
(calculated for C17H22NO
+: 256.1696, and for C17H24NO
+:
258.1852) correspond to 2-(2-heptenyl)-3-methyl-4-quinolinone
and 2-heptanyl-3-methyl-4-quinolinone, respectively (Figure S1),
known antifungal agents originally isolated from ‘‘Pseudomonas
cepacia’’ strain PCII (Moon et al., 1996) (the taxonomic status of
this Bcc isolate is not known). MS/MS analyses indicated that
these compounds contain a common 3-methyl-4-quinoline core
and a heptenyl/heptyl side chain, respectively (Vial et al., 2008).
B. ambifaria has previously been reported to produce thesemole-
cules as quorum-sensing signals (Vial et al., 2008), suggesting
that these Burkholderia secondary metabolites may play multiple
roles. The B. ambifaria AMMDgenome contains a corresponding
2-alkyl-3-methyl-4-quinolinonebiosyntheticgenecluster,hmqA–G
(Bamb_5763–5769), on chromosome 3 approximately 166 kb
downstream of the BAMM polyketide biosynthesis island.
Another fraction afforded an ion with m/z = 702.2446. This
corresponds to the molecular formula of the known polyketide
antibiotic enacyloxin IIa (calculated for C33H46NO11Cl2
+:
702.2442) (Watanabe et al., 1992). This fraction also had an665–677, May 27, 2011 ª2011 Elsevier Ltd All rights reserved 669
Figure 3. Structures of Enacyloxin IIa and
iso-Enacyloxin IIa
(A) A summary of COSY (bold lines), HMBC (black arrows),
and NOESY (dashed arrows) correlations observed for
enacyloxin IIa and iso-enacyloxin IIa.
(B) LC-MS analysis and extracted ion chromatograms
(M+Na) atm/z 724.2200 ± 0.05 for the B. ambifaria AMMD
amberlite resin eluates of the PKS mutants 21-7-2 (top)
and 9-11-5 (middle) and the wild-type strain (bottom);
enacyloxin IIa and iso-enacyloxin signals are absent from
the PKS mutants, linking the pathway to production of the
antibiotics. Data to support the assigned structure are
provided in Tables S2 and S3.
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Enacyloxin Biosynthesis in B. ambifariaabsorbance maximum at 360 nm in the UV/vis spectrum,
consistent with the polyene chromophore of the enacyloxins.
Subsequent LC-MS analysis of chloroform extracts from
B. ambifaria AMMD agar-grown cultures identified two, presum-
ably isomeric, compounds with the same molecular formula as
enacyloxin IIa. These compounds were purified by semiprepara-
tive HPLC. NMR spectroscopic analysis of the compounds iden-
tified them as enacyloxin IIa (Watanabe et al., 1992) and its novel
D-4,5-Z stereoisomer, which we have named iso-enacyloxin IIa
(Figure 3; Tables S2 and S3). LC-MS analyses of XAD-16 eluates
from the mutants containing transposon insertions within the670 Chemistry & Biology 18, 665–677, May 27, 2011 ª2011 Elsevier Ltd All rights resecryptic PKS gene cluster (21-7-2, Bamb_5925
and 9-11-5, Bamb_5919; Figures 1B and 2)
indicated that they did not contain enacyloxins
(Figure 3), unequivocally linking enacyloxin
biosynthesis to this novel biosynthetic island.
The 4-quinolinone metabolites (Figure S1) could
still be detected by LC-MS in the XAD-16
eluates of the mutants, correlating with the re-
tained anticandidal properties of the mutants
(Figure 1B).
Antimicrobial Spectrum
of the B. ambifaria Enacyloxins
Antibiotic susceptibility testing (Table 3) was
performed on enacyloxin IIa and iso-enacyloxin
IIa purified from B. ambifaria. These experi-
ments demonstrated that both had novel and
highly potent activity against B. multivorans,
B. dolosa, and A. baumannii, all of which are
considered pan-resistant Gram-negative path-
ogens. Enacyloxin IIa was approximately
twice as active as iso-enacyloxin IIa (Table 3),
suggesting that the change in the configuration
of the 4,5-double bond in iso-enacyloxin
IIa either reduces its ability to penetrate these
pathogens or, more likely, alters its ability
to bind to its target, the elongation factor Tu
(Parmeggiani et al., 2006). P. aeruginosa and
B. cenocepacia were both resistant to the
maximum concentration tested (100 mg/l). The
purified enacyloxins also lacked inhibitory
activity against C. albicans at 100 mg/l, corre-
lating with the observation that the PKSgene mutants retained their normal anticandidal phenotype
(Figure 1B).
Sequence Analysis of the Enacyloxin Biosynthetic
Gene Cluster
Comparisons of the sequences of the proteins encoded byCDSs
within the genomic island on chromosome 3 with proteins of
known function identified 21 genes hypothesized to be involved
in enacyloxin biosynthesis (Figure 2). Bamb_5925–5920 all
encode proteins with similarity to so-called cis-AT modular
PKSs, in which each module contains an AT domain for loadingrved
Table 3. Activity of Purified Enacyloxin IIa and iso-Enacyloxin IIa
on Bacteria and Yeast
Species and Strain
Minimal Inhibitory Concentration (mg/l)
Enacyloxin IIa iso-Enacyloxin IIa
B. multivorans
ATCC 17616
6.5 14
B. dolosa LMG 18943T 7.5 15
A. baumannii
OXA23 clone 2
3.0 7.0
B. cenocepacia J2315
(LMG 16656T)
>100 >100
P. aeruginosa
NCTC 12903
>100 >100
C. albicans SC5314 >100 >100
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Enacyloxin Biosynthesis in B. ambifariaof the starter or extender unit onto the adjacent acyl carrier
protein (ACP) domain (Figure 4A). Further analysis of each of
these proteins using PKS and conserved domain search
programs (Marchler-Bauer and Bryant, 2004; Yadav et al.,
2003) showed that they constitute a loading module and nine
chain-extension modules (Figure 4A).
The proposed structure of the intermediate assembled on the
module 9 ACP domain (including the stereochemistry of the
hydroxyl groups and the branching methyl group predicted
using the method of Keatinge-Clay, 2007) (Figure S3) corre-
sponds closely to the C-3 to C-23 portion of the polyketide
chain of the proposed structure of enacyloxin IVa, a known
intermediate in the biosynthesis of enacyloxin IIa in Frateuria sp.
W-135 (Furukawa et al., 2007). The ACP-bound intermediate
lacks the chloro groups attached to C-11 and C-18, the
hydroxyl group attached to C-14, and the carbamoyl group
attached to the C-19 hydroxyl group of enacyloxin IVa. These
functional groups are proposed to be introduced by on-PKS
or post-PKS tailoring reactions (vide supra). D-4,5 in the enacy-
loxin IVa polyketide chain is missing in the predicted structure of
the intermediate attached to the module 9 ACP domain,
because module 9 lacks the ketoreductase (KR) domain
required to reduce the b-keto group to the corresponding
hydroxyl group, which would be subsequently eliminated by
the dehydratase (DH) domain to afford the double bond (Fig-
ure 4). Perhaps reduction of this keto group and subsequent
elimination of water is catalyzed by the KR and DH domains
within module 10 of the PKS. This might explain why a mixture
of enacyloxin IIa isomers with D-4,5 geometries is produced by
B. ambifaria. Interestingly, module 6 appears to be lacking a DH
domain that would be expected to be required for introduction
of D-10,11 into the intermediate attached to the ACP domain
of module 10. Presumably, the dehydration reaction required
to introduce this double bond is catalyzed by the module 7
DH domain. The final discrepancy between the predicted struc-
ture of the intermediate attached to the module 9 ACP domain
and the proposed structure of enacyloxin IVa is between the
absolute stereochemistry of C-15 proposed for enacyloxin IVa
and the corresponding stereocenter in the intermediate (Fig-
ure 4). A recent ‘‘J-resolved HMBC-1’’ analysis of enacyloxin
IVa (Furukawa et al., 2007) suggested that it has 15S absolute
stereochemistry, whereas the corresponding stereocenter inChemistry & Biology 18,the intermediate is predicted on the basis of the hypothetical
stereospecificity of the module 4 KR domain to have the 15R
configuration (Keatinge-Clay, 2007). Further experiments will
be needed to resolve this discrepancy.
An unusual feature of modules 2–5 and 7–9 is that they lack the
ATdomains invariably foundwithin conventionalcis-ATPKSs.No
other geneswithin the cluster encodeATs, suggesting that theAT
domain(s) within module 1 and/or module 6 catalyzes in trans
loading of malonyl-CoA extender units onto the ACP domains
within the AT-less PKS modules, as well as in cis loading of
malonyl-CoA extender units onto the ACP domains within their
own modules. Alternatively, loading of malonyl-CoA onto the
ACP domains within the AT-less modules could be catalyzed
by an acyltransferase encoded by a gene lying outside the
enacyloxin biosynthetic gene cluster. A GCN5-related N-acetyl-
transferase (GNAT)-like domain within the loading module is
hypothesized to catalyze decarboxylation of methylmalonyl-
CoA and subsequent transfer of the resulting propionyl-CoA
starter unit onto the adjacent ACP domain. Methylmalonyl-CoA
is a novel substrate for GNAT domains within loading modules,
which hitherto have only been reported to utilize malonyl-CoA
(Gu et al., 2007).
Bamb_5919 encodes a protein that is similar to so-called
trans-AT modular PKSs (Table 2), a group of proteins that is
phylogenetically distinct from the cis-AT PKSs and in which the
modules lack an AT domain for loading of the starter/extender
unit onto the adjacent ACP domain, relying instead on separately
encoded acyltransferases that load starter/extender units
(usually malonyl-CoA) onto the ACP domains (Piel, 2010).
Thus, the enacyloxin assembly line represents only the second
example of a modular PKS that contains a mixture of proteins
belonging to both the cis-AT and trans-AT phylogenetic groups
(Piel, 2010). The other example is the kirromycin PKS, which
consists mostly of proteins with similarity to trans-AT PKSs,
but the last protein within the PKS portion of the assembly shows
sequence similarity to cis-AT PKSs (Weber et al., 2008). Interest-
ingly, kirromycin and enacyloxins have the same target—elonga-
tion factor Tu (EF-Tu) (Parmeggiani and Nissen, 2006). As
expected for trans-AT PKSs, the protein encoded by
Bamb_5919, which constitutes the last module of the enacyloxin
PKS, lacks an AT domain (Figure 4). The lack of any genes
encoding stand-alone ATs within the gene cluster suggests
that the AT domain(s) within module 1 and/or module 6 of the
enacyloxin PKS is responsible for loading malonyl-CoA onto
the ACP domain within this protein. Alternatively, malonyl-CoA
could be loaded onto the ACP domain by an AT encoded by
a gene that lies outside the enacyloxin biosynthetic gene cluster.
Four genes within the genome encoded AT domains with signif-
icant homology to Bamb_5925 and Bamb_5921; in order of
decreasing homology these were Bamb_6476, Bamb_6235,
Bamb_6222, and Bamb_0998. Only Bamb_6476 (an amino
acid adenylation domain-containing protein; 15.37-fold up-
regulation) and Bamb_0998 (a malonyl CoA-acyl carrier protein
transacylase; 2.24-fold upregulation) were expressed under
enacyloxin-inducing conditions, but both at a level considerably
below that of the pathway genes Bamb_5925 and Bamb_5921
(Table 2).
Release of the fully assembled polyketide chain from modular
PKSs normally involvesmacrocyclization or hydrolysis catalyzed665–677, May 27, 2011 ª2011 Elsevier Ltd All rights reserved 671
Figure 4. Proposed Pathway for Enacyloxin Biosynthesis
(A) Domain and module organization of the enacyloxin PKS, showing the proposed structures of chain-elongation intermediates after a and b carbon processing
attached to the ACP domain in each module. The proposed mechanisms for condensation of the fully assembled polyketide chain with DHCCA and subsequent
post-PKS tailoring reactions are shown. Note that the order of the tailoring reactions may be different from that shown and may occur during polyketide chain
assembly rather than after. The structure for enacyloxin IVa proposed by Furukawa et al. (2007) on the basis of NMR experiments is shown in the box. The
discrepancy in the absolute stereochemistry of C-15 between this structure and that predicted for enacyloxin IVa by the ketoreductase stereospecificity model of
Keatinge-Clay (2007) is highlightedby stereochemical descriptors; an alignment of ketoreductasedomains to support this stereospecificity is provided inFigureS3.
(B) Proposed pathway for biosynthesis of DHCCA from 5-dehydroshikimate. B. ambifaria CDS numbers are shown in blue.
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module. The C-terminal domain within the last module of the
enacyloxin PKS is a so-called ketosynthase0 (KS0) domain (Fig-
ure 4). Such domains are common within trans-AT PKSs and
are proposed to catalyze transacylation of intermediates in poly-
ketide assembly from one ACP domain to another (Piel, 2010).
We propose that the KS0 domain within module 10 of the
enacyloxin PKS catalyzes transfer of the fully assembled polyke-
tide chain from the module 10 ACP domain to an ACP domain
within the protein encoded by Bamb_5917. Bamb_5915 en-
codes a protein that is similar to nonribosomal peptide
synthetase condensation domains that is proposed to catalyze
condensation of the C-3 hydroxyl group of (1S, 3R, 4S)-3,4-dihy-
droxycyclohexane carboxylic acid (DHCCA) with the thioester,
to effect polyketide chain release via an unusual mechanism
(Ko¨nig et al., 1997), forming pre-enacyloxins. DHCCA is
proposed to be biosynthesized from shikimate, an intermediate
in aromatic amino acid biosynthesis by the enzymes encoded
by Bamb_5916, Bamb_5914, Bamb_5912, and Bamb_5918
(Figure 4). A putative shikimate dehydrogenase encoded by
Bamb_5913 may boost the levels of shikimate for DHCCA
biosynthesis by reduction of 5-dehydroshikimate.
The pre-enacyloxins are proposed to be converted to decar-
bamoyl-enacyloxin IVa and iso-decarbamoyl-enacyloxin IVa by
the action of a putative FADH2-, O2-, and chloride-dependent
halogenase (Blasiak and Drennan, 2009) which chlorinates
C-11, a putative a-ketoglutarate-, O2-, chloride-, and putative
nonheme iron-dependent chlorinase (Blasiak and Drennan,
2009) which chlorinates C-18, and an a-ketoglutarate-, O2-,
and nonheme iron-dependent dioxygenase (Singh et al., 2008)
which hydroxylates C-14, encoded by Bamb_5928, Bamb_
5931, and Bamb_5927, respectively (Figure 4). Carbamoylation
of decarbamoyl-enacyloxins IVa to give enacyloxin IVa and
iso-enacyloxin IVa is likely catalyzed by the putative carbamoyl-
transferase (Xu et al., 2002) encoded by Bamb_5930. The
conversion of enacyloxin IVa to enacyloxin IIa in Frateuria sp.
W-315 has been shown to be catalyzed by enacyloxin oxidase,
an extracellular pyrroloquinoline quinone (PQQ)-dependent
enzyme with an estimated molecular mass of 73 kDa (Oyama
et al., 1994). Bamb_5932 encodes a putative 71.6 kDa PQQ-
dependent enzyme that is proposed to catalyze the similar
conversion of enacyloxins IVa to enacyloxins IIa in B. ambifaria.
Expression Analysis of B. ambifaria Genes Involved
in Secondary Metabolite Biosynthesis
To map the genes that contribute to the biosynthesis of the
enacyloxins on a global scale, a comparison of B. ambifaria
AMMD gene expression after growth to stationary phase on
glycerol (a carbon source inducing its production) versus glucose
was performed using a custom microarray designed to the
B. ambifaria AMMD genome. Over half the protein-encoding
CDSs in B. ambifaria AMMD were significantly altered in expres-
sion (1.5-fold change, p<0.05) bygrowthonglycerol (3405/6635;
51% of the genomic CDSs), with 2032 CDSs upregulated and
1373 CDSs downregulated (see Supplemental Information;
ArrayExpress experiment accession number E-MEXP-2819).
Nineteen of the 22 gene loci implicated in BAMM biosynthesis
by transposon mutagenesis were significantly altered in expres-
sion (Table 2), corroborating the performance of the AMMDChemistry & Biology 18,custom microarray, a platform which has also been extensively
validated on B. cenocepacia (Drevinek et al., 2008). Six gene
clusters associated with the production of secondary metabo-
lites were significantly upregulated, with the enacyloxin island
and region encoding the AfcA lipopeptide (Kang et al., 1998)
both having an atypical GC content indicative of acquisition by
horizontal gene transfer (Table S4).
Genes within the enacyloxin biosynthesis island were among
the most highly upregulated when B. ambifaria AMMD was
grown to stationary phase on glycerol, with alterations ranging
from 1.6- to 292-fold (Table S4). All the genes proposed to be
involved in the biosynthesis of enacyloxin (Figures 2 and 4)
were significantly upregulated, except forBamb_5913, a putative
shikimate dehydrogenase hypothesized to supply 5-dehydrosh-
ikimate for DHCCA biosynthesis (Figure 4; Table S4). The inter-
conversion of shikimate and 3-dehydroshikimate is a step in
the shikimate pathway for aromatic amino acid biosynthesis.
Thus, Bamb_5913 appears to be redundant, whichmight explain
why its expression is not upregulated under conditions that
induce enacyloxin production. An efflux gene of the multidrug
and toxin extrusion family (MATE), Bamb_5933, was also upre-
gulated 102-fold, suggesting that it may provide the self-resis-
tance pathway for enacyloxin. Both orphan LuxR regulators
(Bamb_5910 and 5911) were also upregulated (Table S4),
corroborating all the previous evidence showing that enacyloxin
biosynthesis was under QS control.
Three other gene clusters correlating the biosynthesis of
known Bcc antifungal antibiotics were also highly expressed
(Table S4): the pyrrolnitrin biosynthetic gene cluster prnA–D
(Bamb_4726–4729) (Schmidt et al., 2009), the 2-heptyl-3-
hydroxy-4(1H)-quinolone (PQS)/4-hydroxy-3-methyl-2-alkylqui-
noline (HMAQ) biosynthetic gene cluster hmqA–G (Bamb_5763–
5769) (Diggle et al., 2006; Vial et al., 2008), and a cluster of 26
genes (Bamb_6128–6153; only Bamb_6149was not significantly
upregulated) within which Bamb_6150 encoded a protein that
washomologous toAfcA implicated in thebiosynthesis of ananti-
fungal lipopeptide from ‘‘P. cepacia’’ (Kang et al., 1998) (a Bcc
isolate of unknown species). Both pyrrolnitrin (Figure S2) and
the HMAQs (Figure S1) were detected in the Amberlite resin
eluates from B. ambifaria AMMD, correlating the expression of
these gene clusters to secondary metabolite secretion. The
AFC lipopeptide appeared not to be present in these extracts.
In addition, two further gene clusters, Bamb_3597–3617 and
Bamb_6468–6482, predicted to direct the production of novel
cryptic secondary metabolites, were also significantly overex-
pressed (Table S4).
DISCUSSION
B. ambifaria Enacyloxin Activity on MDR Pathogens
and Other Burkholderia
We have demonstrated that Bcc bacteria can antagonize the
growth of a range of clinically important pathogens associated
with CF (Lipuma, 2010) and other multidrug-resistant infections
(Coelho et al., 2006), in addition to their well-known antifungal
biological control abilities in the natural environment (Parke
and Gurian-Sherman, 2001). The ability of B. ambifaria to
inhibit MDR Gram-negative bacteria such as B. multivorans,
B. dolosa, and A. baumannii by secretion of enacyloxin IIa665–677, May 27, 2011 ª2011 Elsevier Ltd All rights reserved 673
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the susceptible Burkholderia species all belong to a taxonomi-
cally closely related complex (Coenye and Vandamme, 2003;
Mahenthiralingam et al., 2005). Whereas antagonism toward
fungi and Gram-positive bacteria has been observed in histor-
ical studies of either single isolates or limited collections of Bcc
bacteria (Schmidt et al., 2009; Seyedsayamdost et al., 2010;
Tawfik et al., 2010), the ability of B. ambifaria to inhibit the
growth of closely related intrinsically antibiotic-resistant Bcc
species is significant. The only other Burkholderia antimicrobial
described that has significant activity on another Burkholderia
species is the capistruin peptide of B. thailandensis, which is
active on B. caledonica (Knappe et al., 2008).
Because a large proportion of Bcc isolates screened (Table 1)
produced antimicrobial activity againstC. albicansandS. aureus,
which are also common CF pathogens (Lipuma, 2010), our labo-
ratory-based observation lends weight to the hypothesis that
infection with Bcc bacteria can reduce the polymicrobial content
of sputum. B. ambifaria itself is not a common CF pathogen,
reflecting less than 3%of all Bcc CF infections seen in the United
States (Lipuma, 2010). However, it is a common environmental
Bcc species (Coenye et al., 2001; Ramette et al., 2005). Two of
the six enacyloxin-positive B. ambifaria isolates were recovered
from infected CF patients, with the rest being of environmental
origin. Given the limited number of CF infections caused by
enacyloxin-positive B. ambifaria strains, determining whether
the antibiotic is actually secreted during CF infection will not be
straightforward. B. cenocepacia, which is the second most
common Bcc CF infection (31% of cases; Lipuma, 2010),
possesses significant anticandidal and anti-Gram-positive
activity (Table 1). Thus, after identification of these antimicrobial
metabolites, screening for their presence in CF sputum could
be more readily performed.
Quorum Sensing and Accessory Loci Are Required
for Enacyloxin Secretion
The quorum-sensing-regulated secretion of the enacyloxins by
B. ambifaria is in agreement with the finding that multiple other
Burkholderia antimicrobial secondary metabolites such as
pyrrolnitrin (Schmidt et al., 2009), bactobolin (Seyedsayamdost
et al., 2010), and thailandamide (Ishida et al., 2010) also require
this form of cell-to-cell bacterial communication for their pro-
duction. Although multiple LuxRI-type QS systems may occur
in certain Bcc species such as B. cenocepacia (Malott
et al., 2005), B. ambifaria AMMD only encodes the Bamb_4118
CepI synthase homolog and an adjacent CepR homolog
(Bamb_4116) as the classical, putatively ancestral QS arrange-
ment seen within the Bcc (Malott et al., 2005). The enacyloxin
biosynthesis island encodes two LuxR-type orphan regulators,
Bamb_5910 and Bamb_5911, which are upregulated by 4-fold
(Table 2) and 11-fold (see Supplemental Information), respec-
tively, during antibiotic secretion. Transposon mutation of
Bamb_5910 (Table 2 and Figure 2) abolishes enacyloxin secre-
tion; however, the insertion may have disrupted expression of
both tandemly arranged luxR homologs. Therefore, although
this mutant phenotype clearly links enacyloxin production to
QS regulation, further work will be required to define how each
luxR homolog functions to modulate B. ambifaria gene expres-
sion. Both QS regulator genes reside within the enacyloxin674 Chemistry & Biology 18, 665–677, May 27, 2011 ª2011 Elsevierbiosynthesis genomic island, illustrating the unique capacity for
Burkholderia bacteria to acquire, regulate, and express large,
complex foreign gene clusters. In addition to its QS requirement,
enacyloxin production is also carbon source dependent, sug-
gesting further complexity in antibiotic regulation. Overall, these
findings suggest that future screening of Burkholderia species
for antimicrobial secondarymetabolites should take into account
both metabolic factors and regulatory systems such as QS
dependency.
Although the enacyloxin biosynthesis island appeared to be
relatively self-contained encoding the biosynthetic enzymes
(e.g., PKS modules Bamb_5919–5952) as well as regulators
(e.g., LuxR-type regulators Bamb_5910 and Bamb_5911) and
putative self-resistance proteins (e.g., the MATE efflux protein
Bamb_5933), the mutagenesis and global gene expression
data also implicated multiple accessory loci in enacyloxin secre-
tion. In the context of novel biological functions being linked to
microbial genes, one of the most intriguing genes identified was
the hypothetical gene Bamb_5367, which is located on an RHS-
genetic locus of chromosome 2. Five independent transposon
mutations mapped to Bamb_5367, suggesting this region was
integral to enacyloxin secretion (Table 2). RHS loci have been
linked to type VI secretion systems, and recent bioinformatic
analyses of these VGR proteins indicate that they may evolve
function by acquisition and switching of alternate C-terminal
sequences or tips (Jackson et al., 2009). Our data suggest
that there is a novel link to enacyloxin export for this B. ambifaria
RHS-VGR locus. Although all the transposon mutations in this
region mapped to Bamb_5367, significant upregulation of this
gene was not detected (Table 2). However, both Bamb_5366
and Bamb_5368 were significantly upregulated during enacy-
loxin biosynthesis (2.3- and 1.7-fold, respectively; see Supple-
mental Information), corroborating the involvement of the RHS
locus in antibiotic export and suggesting that Bamb_5368
may act as an alternative C terminus for Bamb_5366. The
high GC content of the PKS genes (Bamb_5919 to 5925 had
a mean GC content of 74.5%; Table S4) within the enacyloxin
biosynthesis island suggests the cluster may have originated
in an actinomycete. The novel involvement of RHS loci in enacy-
loxin secretion suggests that after acquisition of the biosyn-
thesis island, B. ambifaria had to tailor antibiotic secretion to
suite its Gram-negative physiology, illustrating the versatility of
Burkholderia in assembling and expressing complex metabolic
pathways (Chain et al., 2006).
Enacyloxin Biosynthesis and Its Manipulation
to Produce Novel Antibiotics
To date, enacyloxins have only been reported to be produced by
a single bacterial isolate, Frateuria sp. W-315, a Gammaproteo-
bacterium of the family Xanthomonadaceae (Furukawa et al.,
2007). Apart from the PQQ-dependent oxidation reaction that
converts enacyloxin IVa to enacyloxin IIa (Oyama et al., 1994),
nothing is known about enacyloxin biosynthesis in Frateuria.
The discovery of enacyloxin IIa and its novel stereoisomer iso-
enacyloxin IIa as the metabolic products of a cryptic modular
polyketide synthase biosynthetic gene cluster in B. ambifaria
has allowed a plausible pathway for enacyloxin biosynthesis to
beproposed. This hypothetical pathway involves several unusual
or unique features, including only the second example of a hybridLtd All rights reserved
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and trans-AT variants, novel methylmalonyl-CoA specificity for
a GNAT-like domain within a PKS loading module, condensation
domain-mediated polyketide chain release via intermolecular
ester bond formation, a novel route for DHCCA biosynthesis
from shikimate, regiospecific chlorination of a polyene catalyzed
by a flavin-dependent chlorinase (only aromatic rings have
been reported to be chlorinated by such enzymes to date), and
stereospecific hydrocarbon chlorination by a nonheme iron-
and a-ketoglutarate-dependent chlorinase. Remarkably, only
two of the nine PKS chain-extension modules with sequence
similarity to cis-AT proteins appear to contain AT domains,
and no stand-alone ATs are encoded by genes within the enacy-
loxin biosynthetic gene cluster. This suggests that the ACP
domains within the seven PKS modules that are similar to cis-
AT proteins, but lack AT domains, are loaded with malonyl
extender units either by the two modules containing AT domains
or by an AT encoded by a gene lying outside the enacyloxin
biosynthetic gene cluster (although no candidate for this
additional AT was identified in the transposon mutagenesis
experiments, and homology searches only revealed two candi-
date AT-containing genes expressed under enacyloxin-inducing
conditions).
The antibacterial activity of enacyloxins stems from their ability
to inhibit protein synthesis by binding to EF-Tu, which locks the
protein in the GTP-bound conformation (regardless of whether
GTP or GDP is bound), preventing release of aminoacyl-tRNA
after delivery to the acceptor site of the ribosome (Parmeggiani
et al., 2006). Interestingly, the expression of multiple ribosomal
and regulatory RNAs is upregulated during enacyloxin biosyn-
thesis (see Supplemental Information), suggesting that their
overproduction may contribute to the enacyloxin resistance in
B. ambifaria. The X-ray crystal structure of enacyloxin IIa bound
to a complex of EF-Tu with a nonhydrolyzable GTP analog
pinpoints important functional groups in the antibiotic that
interact with the elongation factor. This information coupled
with the proposed pathway for enacyloxin biosynthesis should
stimulate future biosynthetic engineering efforts to produce
novel enacyloxin analogs with potential applications in the treat-
ment of MDR Gram-negative infections.
SIGNIFICANCE
Gram-negative B. cepacia complex bacteria are known for
their ability to secrete a range of antifungal secondary
metabolites that contribute to their biopesticidal phenotype.
Bcc bacteria also cause human opportunistic infections in
individuals with CF. However, it is not known whether
they can antagonize the growth of other pathogens which
infect the lungs of these individuals. Recent revisions in
Bcc taxonomy and our curiosity about the ability of Bcc
bacteria to compete with other CF pathogens stimulated
us to perform a systematic survey of Bcc antimicrobial
secretion. Of 268 representative Bcc isolates screened,
85 were antifungal, 64 were anti-Gram positive, and 6
B. ambifaria isolates inhibited a range of multidrug-resistant
(MDR) Gram-negative bacteria including the CF pathogen
B. multivorans. Using transposon mutagenesis and global
gene expression analysis, production of the B. ambifariaChemistry & Biology 18,antibacterial was mapped to a cluster of cryptic, quorum-
sensing-regulated genes within the genome of B. ambifaria
strain AMMD, several of which encode proteins that are
similar to modular polyketide synthases (PKSs). Isolation
and structure elucidation demonstrated that the antibiotic
was amixture of enacyloxin IIa, an unusual polyene targeting
elongation factor Tu, and a stereoisomer we designated iso-
enacyloxin IIa. Sequence analysis of the proteins encoded
within the enacyloxin biosynthetic gene cluster allowed
a complete hypothetical pathway for enacyloxin biosyn-
thesis to be proposed. This pathway involves several
distinctive features including a very unusual hybrid cis-acyl-
transferase (cis-AT)/trans-AT PKS consisting of a loading
module containing a GCN5-related N-acetyltransferase
domain that appears to be specific for methylmalonyl-CoA,
nine chain-extension modules with sequence similarity to
cis-AT PKSs (seven of which lack AT domains), and a single
AT-less chain-extension module with sequence similarity to
trans-AT PKSs. These findings suggest that the Bcc may be
an underexploited resource for the discovery of antibiotics
with distinctive biosynthetic pathways and potent activity
against MDR pathogens.
EXPERIMENTAL PROCEDURES
Strains and Culture Conditions
All Burkholderia isolates were drawn from previous studies (Mahenthiralingam
et al., 2008) and had been accurately identified to the species level by
either MLST (Baldwin et al., 2005) or recA sequence analysis (Payne et al.,
2005). Genome-sequenced Bcc strains used were as follows: B. lata
383, B. multivorans ATCC 17616, B. ambifaria AMMD, B. ambifaria MC40-6,
B. vietnamiensis G4, B. cenocepacia J2315, B. cenocepacia HI2424,
B. cenocepacia AU1054, and B. cenocepacia IIIB MC0-3, with sequence data
available at the Burkholderia Genome Database (http://www.burkholderia.
com), andB. contaminans LMG23255, forwhich theBurkholderiaSAR-1meta-
genome serves as a reference sequence (Mahenthiralingam et al., 2006). Other
representative Bcc isolates examinedwereB. cepaciaATCC25416T,B. dolosa
LMG 18943, B. cenocepacia BCC0524, B. cenocepacia IIIA, B. cenocepacia
BCC0048, B. stabiliz LMG 18888, B. cenocepacia CZ1238, B. cenocepacia
BCC1434, and B. cenocepacia BCC1436. The growth of Burkholderia
(at 30C)was carried out on tryptic soyamedium,whereas production of antibi-
oticswasperformedon aminimal saltsmediumwith 4 g/l glycerol as the carbon
source (BSM-G; O’Sullivan et al., 2007). Antibiotic susceptibility testing was
carried out using a standardized broth microdilution assay (Rose et al., 2009)
with a maximum concentration of 100 mg/l enacyloxin tested.
Antimicrobial Activity Screens
A classical overlay assay was used to screen for antimicrobial activity (see
Supplemental Information). Briefly, each Bcc strain was grown as a single
colony on BSM-G agar, killed with chloroform vapor after growth, and overlaid
with soft Isosensitest agar (Oxoid) seeded with a susceptibility-testing refer-
ence species. Antimicrobial activity was scored by measuring the zone of
clearing (mm) around the Bcc colony; in the initial screen of the Bcc collection
isolates, those producing a zone of clearing greater than 10 mm were scored
as positive for antimicrobial activity (Table 1).
Transposon Mutagenesis and Genome Mapping
B. ambifaria strain AMMD was subjected to transposon mutagenesis with
mini-Tn5-Km2 as described (O’Sullivan et al., 2007) and a bank of 1920
mutants was created. Mutants were screened for reduction, loss of, and
increased activity against B. multivorans ATCC 17616 using the overlay assay.
The loci flanking the transposon insertions were sequenced (O’Sullivan et al.,
2007) and correlated to the B. ambifaria AMMD genome using the web data-
base http://www.burkholderia.com.665–677, May 27, 2011 ª2011 Elsevier Ltd All rights reserved 675
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PCR primers were designed to amplify the B. ambifaria AMMD PKS genes
Bamb_5925, Bamb_5921, and Bamb_5919 (see Supplemental Information).
A standard PCR amplification was performed on BAMM-positive
B. ambifaria strains, and amplification products were subjected to DNA
sequence analysis to corroborate their identity as previously described (Payne
et al., 2005).
Global Gene Expression Analysis
Custom gene expressionmicroarrays based on Agilent 60-mer SurePrint tech-
nology were designed to the genome sequence of B. ambifaria strain
AMMD by Oxford Gene Technology (ArrayExpress [http://www.ebi.ac.uk/
arrayexpress] design number A-MEXP-1839). B. ambifaria AMMD gene
expression induced by growth on glycerol was compared to that on glucose
as previously described (Drevinek et al., 2008) (see Supplemental Information)
with three replicate experiments performed. Arrays were scanned and pro-
cessed for bioinformatic analysis using GeneSpring GX version 7.3.1 as
described (Drevinek et al., 2008), and the experiment was submitted to
ArrayExpress (accession number E-MEXP-2819). Genes which altered
expression by greater than 1.5-fold (p < 0.05) after growth on glycerol were
identified (see Supplemental Information).
Antibiotic Isolation, Structure Elucidation, and Detection
Antibiotics were isolated by adsorption onto an Amberlite XAD-16 neutral
crosslinked polystyrene resin (Ribeiro and Ribeiro, 2003) and subsequently
eluted with methanol (see Supplemental Information). Semipreparative
HPLC was used to purify antibiotics, and fractions were analyzed by
HR-MS. The structures of the products of the cryptic PKS cluster were eluci-
dated using a combination of HR-MS, MS/MS, and NMR experiments as
described (see Supplemental Information). All formulas generated from the
parent ion and fragment ions are consistent with the molecular formula of en-
acyloxin IIa (Figures 3 and 4). LC-MS analyses were applied to the XAD-16
eluates of AMMD and transposon mutants (Bamb_5925 and Bamb_5919;
Figure 1) to correlate mutation of the PKS cluster with abrogation of enacyloxin
biosynthesis (see Supplemental Information).
ACCESSION NUMBERS
The custom B. ambifaria AMMD microarray design has been submitted to
ArrayExpress (http://www.ebi.ac.uk/arrayexpress) under design number
A-MEXP-1839. The microarray data for the experiment comparing
B. ambifaria AMMDgene expression under antibiotic-inducing and -noninduc-
ing growth conditions have been submitted to ArrayExpress under experiment
accession number E-MEXP-2819.
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